BusinessAytu BioPharma Exceeds Q4 2026 Revenue Forecast
Aytu BioPharma reported revenue for the fourth quarter of 2026 that surpassed analyst forecasts. The earnings call transcript revealed stronger-than-expected financial performance, highlighting the company's growth and market position during this period.
Investing India·23h ago

